Karuna Therapeutics Inc
KRTX
Market Cap$0
Close$
$4.56
98.6% downside
Current Fair Value
98.6% downsideOvervalued by 98.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $0.00 |
|---|---|
| Enterprise Value | $-1,262,813,000.00 |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-11.73 |
| Beta | 0.0 |
| Outstanding Shares | 38,199,272 |
| Avg 30 Day Volume | 0 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 0.0 |
|---|---|
| PEG | 0.0 |
| Price to Sales | - |
| Price to Book Ratio | 10.31 |
| Enterprise Value to Revenue | -1930.91 |
| Enterprise Value to EBIT | 2.55 |
| Enterprise Value to Net Income | 2 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
ESG Score
No data